Directory
>
Phil Chamberlain
Phil Chamberlain
Co-Founder, President and CEO | Neomorph, Inc.
San Diego, California, United States
Phil Chamberlain
Summary
Phil Chamberlain is a distinguished biotechnology leader based in San Diego, California, specializing in innovative drug discovery methods, particularly in targeted protein degradation. His extensive background in structural and chemical biology has facilitated groundbreaking research, including the first structure of thalidomide bound to human cereblon. As the co-founder and CEO of Neomorph, he focuses on developing molecular glue drugs that target previously 'undruggable' proteins. With a Ph.D. from the University of Oxford, Phil has held executive positions at major pharmaceutical companies, including Bristol Myers Squibb and Celgene. His prolific publication record highlights his contributions to the field, particularly in the mechanisms of cereblon modulators. Phil's passion for advancing therapeutic modalities is matched by his commitment to addressing critical health challenges. He is recognized not only for his scientific expertise but also for his leadership in fostering innovation within the biotechnology sector.
Phil Chamberlain
Work Experience
Co-Founder, President and CEO at
Neomorph, Inc.
February 2020 - Present
Executive Director, Protein Homeostasis and Structural Biology at
Bristol Myers Squibb
November 2019 - February 2020
Executive Director at
Bristol Myers Squibb
December 2007 - November 2019
Postdoctoral Associate / Institute Fellow at
GNF
January 2004 - January 2007
Doctoral Student at
University Of Oxford
January 2000 - January 2004
Howard Hughes Undergraduate Fellow at
Mount Sinai School Of Medicine
January 1998 - January 1998
Phil Chamberlain
Education
University of Oxford, D.Phil.
January 1999 - January 2003
January 1996 - January 1999
Frequently Asked Questions about Phil Chamberlain
What is Phil Chamberlain email address?
Phil Chamberlain's primary email address is ****@neomorph.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Phil Chamberlain work for?
Phil Chamberlain is a Co-Founder, President and CEO at Neomorph, Inc., a company specializing in Drugs, proprietaries, & sundries.
Where Phil Chamberlain graduated from?
Phil Chamberlain holds a degree in Structural Biology from University of Oxford.
How can I directly contact Phil Chamberlain?
To contact Phil Chamberlain directly, you can use the email address ****@neomorph.com. Complete contact information is available upon registration with Muraena.
Who is Phil Chamberlain?
Phil Chamberlain is a distinguished biotechnology leader based in San Diego, California, specializing in innovative drug discovery methods, particularly in targeted protein degradation. His extensive background in structural and chemical biology has facilitated groundbreaking research, including the first structure of thalidomide bound to human cereblon. As the co-founder and CEO of Neomorph, he focuses on developing molecular glue drugs that target previously 'undruggable' proteins. With a Ph.D. from the University of Oxford, Phil has held executive positions at major pharmaceutical companies, including Bristol Myers Squibb and Celgene. His prolific publication record highlights his contributions to the field, particularly in the mechanisms of cereblon modulators. Phil's passion for advancing therapeutic modalities is matched by his commitment to addressing critical health challenges. He is recognized not only for his scientific expertise but also for his leadership in fostering innovation within the biotechnology sector.
Phil`s contact details
****@neomorph.com
Colleagues
VP, Data Sciences
VP of Chemistry
Vice President, Head of Human Resources & Talent Acquisition
Chief Financial Officer
Vice President, Business Development
Vice President, Molecular Sciences